Torben Bjerregaard Larsen

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. pmc Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
    Sian Robinson
    Department of Anaesthesia and Intensive Care, Odense University Hospital OUH, SDR, Odense C, Denmark
    Crit Care 14:R41. 2010
  2. ncbi request reprint The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 89:211-5. 1998
  3. ncbi request reprint ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study
    T B Larsen
    Department of Clinical Biochemistry and Genetics, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense, Denmark
    J Thromb Haemost 3:300-4. 2005
  4. ncbi request reprint Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins
    Torben Bjerregaard Larsen
    Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark
    Epidemiology 14:328-32. 2003
  5. ncbi request reprint Platelets and anticoagulant capacity in patients with inflammatory bowel disease
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    Pathophysiol Haemost Thromb 32:92-6. 2002
  6. ncbi request reprint Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays
    T B Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    J Intern Med 252:36-40. 2002
  7. ncbi request reprint Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
    Larsen T Bjerregaard
    Dept of Clinical Biochemistry, Aalborg Hospital, Denmark
    Scand J Gastroenterol 37:62-7. 2002
  8. ncbi request reprint Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Vejle, Denmark
    Thromb Res 98:233-9. 2000
  9. ncbi request reprint Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 92:157-62. 1998
  10. ncbi request reprint Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study
    Torben Bjerregaard Larsen
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Thromb Res 120:505-9. 2007

Collaborators

Detail Information

Publications27

  1. pmc Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial
    Sian Robinson
    Department of Anaesthesia and Intensive Care, Odense University Hospital OUH, SDR, Odense C, Denmark
    Crit Care 14:R41. 2010
    ..This study aims to determine the subcutaneous (SC) dose of enoxaparin that would give the best anti-factor Xa levels in ICU patients...
  2. ncbi request reprint The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 89:211-5. 1998
    ..Equal gender distribution was found, and the Arg506Gln mutation is probably not a considerable risk factor in fetal life in the general population...
  3. ncbi request reprint ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study
    T B Larsen
    Department of Clinical Biochemistry and Genetics, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense, Denmark
    J Thromb Haemost 3:300-4. 2005
    ..To examine possible associations of ABO blood types with the risk of venous thromboembolism (VTE) in pregnancy and the puerperium...
  4. ncbi request reprint Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins
    Torben Bjerregaard Larsen
    Department of Clinical Epidemiology, Aarhus University Hospital, Aalborg, Denmark
    Epidemiology 14:328-32. 2003
    ..Although several genetic determinants (mutations or polymorphisms) have been associated with increased risk of venous thromboembolism, the overall influence of genetic factors on this disease is unknown...
  5. ncbi request reprint Platelets and anticoagulant capacity in patients with inflammatory bowel disease
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    Pathophysiol Haemost Thromb 32:92-6. 2002
    ....
  6. ncbi request reprint Validity of D-dimer tests in the diagnosis of deep vein thrombosis: a prospective comparative study of three quantitative assays
    T B Larsen
    Department of Clinical Biochemistry, Section for Thrombosis and Hemostasis, Aalborg Hospital, Aalborg, Denmark
    J Intern Med 252:36-40. 2002
    ..A third assay (Auto Dimer) became available during sample collection and has been included in the final assessment. The diagnostic performance of the Auto Dimer assay was evaluated on three different coagulation analysers...
  7. ncbi request reprint Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease
    Larsen T Bjerregaard
    Dept of Clinical Biochemistry, Aalborg Hospital, Denmark
    Scand J Gastroenterol 37:62-7. 2002
    ....
  8. ncbi request reprint Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Vejle, Denmark
    Thromb Res 98:233-9. 2000
    ....
  9. ncbi request reprint Effect of anticoagulant therapy on the hypercoagulable state in patients carrying the factor V Arg506Gln mutation
    T B Larsen
    Department of Clinical Biochemistry, Vejle County Central Hospital, Denmark
    Thromb Res 92:157-62. 1998
    ..Thus, it seems that OAT with standard treatment doses is just as effective in patients with the Arg506Gln mutation as in comparable controls without the mutation...
  10. ncbi request reprint Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study
    Torben Bjerregaard Larsen
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Thromb Res 120:505-9. 2007
    ..The aim of the present study was to examine the association between smoking, obesity (BMI>30), and risk for venous thromboembolism (VTE) during pregnancy and the puerperium...
  11. doi request reprint Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study
    Torben Bjerregaard Larsen
    Department of Cardiology, Cardiovascular Research Centre, Aalborg University Hospital, Aalborg, Denmark
    J Am Coll Cardiol 61:2264-73. 2013
    ....
  12. doi request reprint Alcohol intake and prognosis of atrial fibrillation
    Thure Filskov Overvad
    Department of Cardiology, Cardiovascular Research Centre, Aalborg University Hospital, Aalborg, Denmark
    Heart 99:1093-9. 2013
    ..To assess alcohol intake as a risk factor for adverse events among patients with incident atrial fibrillation (AF)...
  13. doi request reprint Body mass index and adverse events in patients with incident atrial fibrillation
    Thure Filskov Overvad
    Department of Cardiology, Cardiovascular Research Centre, Aalborg University Hospital, Aalborg, Denmark
    Am J Med 126:640.e9-17. 2013
    ..To date, no anthropometric measure is included in any risk stratification scheme for stroke and death in atrial fibrillation patients...
  14. pmc Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
    Lars Hvilsted Rasmussen
    Thrombosis Research Unit, Aalborg University, Aalborg, Denmark
    BMJ 345:e7097. 2012
    ..A secondary objective was to do the same analysis in the primary prevention cohort...
  15. doi request reprint Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study
    Torben Bjerregaard Larsen
    Department of Cardiology, Aalborg AF Study Group, Cardiovascular Research Centre, Aarhus University Hospital, Aalborg, Denmark
    Circ Cardiovasc Qual Outcomes 5:335-42. 2012
    ..The objective of this study was to evaluate the added predictive ability of the CHA(2)DS(2)VASc prediction rule for stroke and death in a nonanticoagulated population of patients with atrial fibrillation...
  16. ncbi request reprint A review of medical records and discharge summary data found moderate to high predictive values of discharge diagnoses of venous thromboembolism during pregnancy and postpartum
    Torben Bjerregaard Larsen
    Department of Clinical Biochemistry and Genetics, Section for Thrombosis and Haemostasis, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense, Denmark Department of Clinical Epidemiology, Aarhus University Hospitals, DK 8000, Aarhus C, Denmark
    J Clin Epidemiol 58:316-9. 2005
    ....
  17. doi request reprint Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients
    Mogens Tornby Stender
    Department of Surgical Gastroenterology A, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18 22, Aalborg, Denmark
    Thromb Haemost 99:396-400. 2008
    ..In conclusion, the combined use of pre-test probability and D-dimer test may be useful in ruling out preoperative DVT in colorectal cancer patients admitted for surgery...
  18. ncbi request reprint [Diagnostics: new methodological initiatives]
    Erik Magid
    Amager Hospital, Klinisk Biokemisk Afdeling
    Ugeskr Laeger 166:1664-6. 2004
  19. doi request reprint Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis
    Ida Ehlers Albertsen
    University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham B18 7QH, United Kingdom
    Stroke 44:1329-36. 2013
    ..Our aim was to identify the risk factors that contribute to stroke risk in atrial fibrillation, although patients were taking OACs in a clinical trial setting...
  20. doi request reprint Monitoring of anticoagulant therapy applying a dynamic statistical model
    Peter Brønnum Nielsen
    Department of Cardiology, Aalborg AF Study Group, Cardiovascular Research Centre, Aalborg Hospital, Srd Skovvej 15, Denmark
    Comput Methods Programs Biomed 110:380-8. 2013
    ..Retrospective test of the model proved robustness to choices of initial parameters, and feasible prediction results of both INR values and suggested warfarin dosage, which may prove beneficial for both patients and healthcare takers...
  21. doi request reprint Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
    Gregory Y H Lip
    University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
    J Am Coll Cardiol 60:738-46. 2012
    ..This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative efficacy and safety against each other...
  22. doi request reprint Self-testing and self-management of oral anticoagulation therapy in children
    Thomas Decker Christensen
    Thomas Decker Christensen, Department of Cardiothoracic and Vascular Surgery and Institute of Clinical Medicine, Aarhus University Hospital, Skejby, DK 8200 Aarhus N, Denmark
    Thromb Haemost 106:391-7. 2011
    ....
  23. ncbi request reprint High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer
    M T Stender
    Department of Surgical Gastroenterology, Aalborg Hospital, Aarhus University Hospital, Hobrovej 18 22, DK 9100 Aalborg, Denmark
    Br J Surg 94:1100-3. 2007
    ..The aim of this observational study was to estimate the preoperative prevalence of DVT in patients with colorectal cancer...
  24. ncbi request reprint Evaluation of a simple dosage scheme for transition from phenprocoumon to warfarin in oral anticoagulation
    C Kristiansen
    Department of Clinical Biochemistry, Vejle County Central Hospital, DK 7100, Vejle, Denmark
    Thromb Res 98:157-63. 2000
    ..No patients experienced haemorrhages or thromboembolic complications during the period of changeover. In conclusion, the proposed scheme for changing medication from phenprocoumon to warfarin is safe and convenient...
  25. doi request reprint Denaturing high-performance liquid chromatography mutation analysis in patients with reduced Protein S levels
    Lise Bathum
    Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Denmark
    Clin Chim Acta 390:76-81. 2008
    ..The aim was to design a high-throughput genetic analysis based on denaturing high-performance liquid chromatography to identify sequence variations in the gene coding for Protein S...
  26. ncbi request reprint [The Danish clinical guidelines (Klaringsrapporter, 1996-2001: Insufficient evidence presented for the diagnostic accuracy of recommended clinical-biochemical tests]
    Per E Jørgensen
    Odense Universitetshospital, Afdeling KKA
    Ugeskr Laeger 166:1667-70. 2004
  27. doi request reprint More studies on outcomes using biochemical diagnostic tests are needed: findings from the Danish Society of Clinical Biochemistry
    Jonna Skov Madsen
    Clin Chem 54:1254-6. 2008